SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Dynavax Technologies Corp. of a Class Action Lawsuit & a Lea...
December 28 2016 - 3:43PM
Business Wire
The following statement is being issued by Levi & Korsinsky,
LLP:
To: All persons or entities who purchased or otherwise
acquired securities of Dynavax Technologies Corporation
(NASDAQ:DVAX) between March 10, 2014 and
November 11, 2016. You are hereby notified that a
securities class action lawsuit has been commenced in the USDC for
the Northern District of California. To get more information go
to:
http://www.zlk.com/pslra/dynavax-technologies
or contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877)
363-5972. There is no cost or obligation to you.
The complaint alleges that during the Class Period Dynavax made
false and/or misleading statements and/or failed to disclose that:
(i) the phase 3 HBV-23 trial for the Company’s lead vaccine product
HEPLISAV-B was not designed in accordance with the U.S. Food and
Drug Administration’s concerns and issues, as pointed out in a 2013
Complete Response Letter; (ii) Dynavax failed to provide sufficient
information to the FDA in its Revised Biologics License Application
for the drug; (iii) Dynavax’s resources will not be sufficient for
the Company to advance the HEPLISAV-B program on its own; and (iv)
as a result of the foregoing, the Company’s financial statements,
as well as Defendants’ statements about Dynavax’s business,
operations, and prospects, were false and misleading and/or lacked
a reasonable basis.
If you suffered a loss in Dynavax you have until January 17, 2017 to request that the Court
appoint you as lead plaintiff. Your ability to share in any
recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, California, Connecticut, and Washington D.C. The
firm’s attorneys have extensive expertise and experience
representing investors in securities litigation, and have recovered
hundreds of millions of dollars for aggrieved shareholders.
Attorney advertising. Prior results do not guarantee similar
outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161228005409/en/
Levi & Korsinsky, LLPJoseph E. Levi, Esq.Tel:
212-363-7500Toll Free: 877-363-5972Fax: 212-363-7171www.zlk.com
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Apr 2023 to Apr 2024